Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy

Documenti analoghi

• Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction Syndrome
  di: Matthew J. Foglia, et al.
  Pubblicazione: (2024)
• Multiday Use of Non‐Tunneled Central Venous Catheters in Vetted Adult Outpatients Undergoing Apheresis Collections of Autologous Peripheral Blood Stem Cells Is Feasible and Well Tolerated
  di: Andres E. Mindiola Romero, et al.
  Pubblicazione: (2026)
• An Abbreviated Course of Therapeutic Plasma Exchange Does Not Affect Platelet Count Recovery or Durability in Patients With Immune Thrombotic Thrombocytopenic Purpura Receiving Caplacizumab
  di: Jay S. Raval, et al.
  Pubblicazione: (2026)
• Refinement of Replacement Fluid Using Human Serum Albumin Preparation to Enhance Biocompatibility in Therapeutic Plasma Exchange
  di: Yuki Narita, et al.
  Pubblicazione: (2025)
• Development of a Novel Calculation Tool for Mixed Replacement Therapy Using Fresh Frozen Plasma and Albumin for Therapeutic Plasma Exchange
  di: Yosuke Imamura, et al.
  Pubblicazione: (2026)